Impact of doxofylline in COPD: A pairwise meta-analysis
Open Access
- 1 August 2018
- journal article
- research article
- Published by Elsevier BV in Pulmonary Pharmacology & Therapeutics
- Vol. 51, 1-9
- https://doi.org/10.1016/j.pupt.2018.04.010
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- The mechanism of action of doxofylline is unrelated to HDAC inhibition, PDE inhibition or adenosine receptor antagonismPulmonary Pharmacology & Therapeutics, 2012
- Doxofylline and Theophylline: A Comparative Clinical StudyJournal of Clinical and Diagnostic Research, 2012
- GRADE guidelines: 9. Rating up the quality of evidenceJournal of Clinical Epidemiology, 2011
- GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tablesJournal of Clinical Epidemiology, 2011
- Doxofylline: A “Novofylline”Pulmonary Pharmacology & Therapeutics, 2010
- TheophyllinePharmaceuticals, 2010
- Doxofylline: a promising methylxanthine derivative for the treatment of asthma and chronic obstructive pulmonary diseaseExpert Opinion on Pharmacotherapy, 2009
- Meta-analysis: Methods, strengths, weaknesses, and political usesJournal of Laboratory and Clinical Medicine, 2006
- How should meta‐regression analyses be undertaken and interpreted?Statistics in Medicine, 2002
- Statistical Power AnalysisCurrent Directions in Psychological Science, 1992